|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thoracic Aortic Surgery Program, Divisions of Cardiothoracic and Vascular Surgery, Virginia Commonwealth University Medical Center, Medical College of Virginia Campus, West Hospital Building, 7th Floor, South Wing, 1200 E Broad St, PO Box 980068, Richmond VA 23298-0068
(Email: dbrinster@mcvh-vcu.edu).
| The first 20% of the full text of this article appears below. |
This article by Botta and colleagues [1] documents the results of a single institutional experience in the treatment of penetrating atherosclerotic ulcers (PAUs) of the descending thoracic aorta with endovascular stent grafts in 19 patients. The technical success rate was stated as 18 of 19 cases (95%) and defined as successful insertion and deployment of the stent graft; however, there was 11% mortality from multisystem organ failure and also 3 patients (16%) with endoleaks. One patient required surgical treatment for correction of the endoleak, 1 patient required additional endografting, and 1 patient had spontaneous resolution. Late mortality was 4 of 17 (24%) in those patients surviving after 30 days, all from nonaortic causes, with the median follow-up period of 22 months. Therefore, there was an overall 32% mortality, including the two early deaths.
The risk of PAUs has been debated since their
Related Article
Ann. Thorac. Surg. 2008 85: 987-992.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |